Fund shareholders of OSE Immunotherapeutics SA

Name: Fund shareholders of OSE Immunotherapeutics SA
Creator: Titelia
License: https://titelia.com/en/sources

ISIN FR0012127173 · SIREN 479 457 715 · France · LEI 969500HIUWVGY6NZSM05

Fund shareholders: 3
Of which ETFs: 2 1 other fund
Value held: 83.9K $
Share of capital: 0.1 % of 23.6M shares on Jun 5, 2026

Fund	Shares	Value	Share of capital
Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust	9,383	42.1K $	0.04 %	as of Apr 30, 2026 ↗
Dimensional International Small Cap ETF Dimensional ETF Trust	6,434	28.9K $	0.03 %	as of Apr 30, 2026 ↗
THE CONTINENTAL SMALL COMPANY SERIES DFA INVESTMENT TRUST CO	2,885	13K $	0.01 %	as of Apr 30, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

Fund	Weight in fund
Dimensional International Small Cap ETF Dimensional ETF Trust	0.00 %	as of Apr 30, 2026 ↗
Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust	0.00 %	as of Apr 30, 2026 ↗
THE CONTINENTAL SMALL COMPANY SERIES DFA INVESTMENT TRUST CO	0.00 %	as of Apr 30, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

Quarter	Shareholders	Change	Shares	Change
2026Q2	3	-3	18,702	-42.1 %
2026Q1	6	+1	32,321	+39.8 %
2025Q4	5	0	23,117	+0.2 %
2025Q3	5		23,061

Threshold crossings on OSE Immunotherapeutics SA

1 threshold crossing was filed with the AMF (article L.233-7 of the French commercial code). The stake is the one the filer states holding on that day.

Shareholder	Crossing	Declared stake
M. Nicolas Poirrier	below 5 % of the capital and voting rights	3.43 %	as of Oct 2, 2025

Cite this page

Titelia. "Fund shareholders of OSE Immunotherapeutics SA". https://titelia.com/en/stocks/ose-immunotherapeutics-sa-FR0012127173